Literature DB >> 3548507

Prediction of pulmonary function abnormalities after adult respiratory distress syndrome (ARDS).

C G Elliott, B Y Rasmusson, R O Crapo, A H Morris, R L Jensen.   

Abstract

To determine if measures of ARDS severity during the acute illness correlate with lung function after recovery from ARDS, we regressed lowest total thoracic compliance (CTH), initial intrapulmonary shunt fraction (Qsp/Qt), initial mean pulmonary artery pressure (PAP), maximal level of positive end-expiratory pressure (PEEP), time ventilated (Tvent), and time with FlO2 greater than 0.6 (TO2) against the percent of predicted FVC, TLC, and DLCO of 16 previously healthy, nonsmoking ARDS survivors. Pulmonary function tests were performed more than 1 yr after ARDS. Percent of predicted FVC correlated with CTH (r = 0.66, p less than 0.01) and PAP (r = 0.53, p less than 0.05), and percent of predicted TLC correlated with CTH (r = 0.71, p less than 0.01), PEEP (r = -0.55, p less than 0.05), and Qsp/Qt (r = -0.53, p less than 0.05). Only TO2 correlated with percent of predicted DLCO (r = -0.53, p less than 0.05). Five of 7 ARDS survivors with an abnormal DLCO were supported at FlO2 greater than 0.6 for more than 24 h, whereas all of 9 survivors with a normal DLCO received FlO2 greater than 0.6 for less than 24 h. We conclude that physiologic markers of ARDS severity during the acute illness correlate with residual pulmonary dysfunction after recovery from ARDS. Support with FlO2 greater than 0.6 for more than 24 h appears to be a sensitive and specific predictor of an abnormally reduced DLCO more than 1 yr after ARDS.

Entities:  

Mesh:

Year:  1987        PMID: 3548507     DOI: 10.1164/arrd.1987.135.3.634

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  11 in total

Review 1.  The pulmonary physician and critical care. 2. The injured lung: conventional and novel respiratory therapy.

Authors:  A Swami; B F Keogh
Journal:  Thorax       Date:  1992-07       Impact factor: 9.139

2.  Acute respiratory distress syndrome: a historical perspective.

Authors:  Gordon R Bernard
Journal:  Am J Respir Crit Care Med       Date:  2005-07-14       Impact factor: 21.405

3.  Inflammation-induced caveolin-1 and BMPRII depletion promotes endothelial dysfunction and TGF-β-driven pulmonary vascular remodeling.

Authors:  Suellen D S Oliveira; Maricela Castellon; Jiwang Chen; Marcelo G Bonini; Xiaowu Gu; Michael H Elliott; Roberto F Machado; Richard D Minshall
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-02-10       Impact factor: 5.464

Review 4.  The long-lasting effects of the acute respiratory distress syndrome.

Authors:  Matthew F Mart; Lorraine B Ware
Journal:  Expert Rev Respir Med       Date:  2020-03-17       Impact factor: 3.772

5.  Severe pulmonary dysfunction following acute respiratory distress syndrome.

Authors:  H R Smith; D G Sinclair
Journal:  Postgrad Med J       Date:  1996-09       Impact factor: 2.401

Review 6.  Long-Term Outcomes in Acute Respiratory Distress Syndrome: Epidemiology, Mechanisms, and Patient Evaluation.

Authors:  Jessica A Palakshappa; Jennifer T W Krall; Lanazha T Belfield; D Clark Files
Journal:  Crit Care Clin       Date:  2021-05-27       Impact factor: 3.879

7.  Sequelae of the adult respiratory distress syndrome.

Authors:  R Hert; R K Albert
Journal:  Thorax       Date:  1994-01       Impact factor: 9.139

Review 8.  The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis.

Authors:  Benjamin D Bringardner; Christopher P Baran; Timothy D Eubank; Clay B Marsh
Journal:  Antioxid Redox Signal       Date:  2008-02       Impact factor: 8.401

Review 9.  Recovery and outcomes after the acute respiratory distress syndrome (ARDS) in patients and their family caregivers.

Authors:  Margaret S Herridge; Marc Moss; Catherine L Hough; Ramona O Hopkins; Todd W Rice; O Joseph Bienvenu; Elie Azoulay
Journal:  Intensive Care Med       Date:  2016-03-30       Impact factor: 17.440

10.  Plasma Insulin-like Growth Factor Binding Protein 7 Contributes Causally to ARDS 28-Day Mortality: Evidence From Multistage Mendelian Randomization.

Authors:  Xuesi Dong; Zhaozhong Zhu; Yongyue Wei; Debby Ngo; Ruyang Zhang; Mulong Du; Hui Huang; Lijuan Lin; Paula Tejera; Li Su; Feng Chen; Amy M Ahasic; B Taylor Thompson; Nuala J Meyer; David C Christiani
Journal:  Chest       Date:  2020-11-12       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.